Revised forecast
Fiscal year ending June 2026 · Full yearPrevious forecast published 13 November 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Acquisition and sales in INVASE's real estate transaction model have remained strong. In the Mogecheck business, efficient investment in advertising and promotional expenses progressed, while the INVASE business was temporarily affected in the third quarter by changes to banks' screening criteria.
| Item | Details |
|---|---|
| Net Sales | ¥3,779 million → ¥8,092 million（+114.1%） |
| Operating profit | ¥195 million → ¥200 million（+2.5%） |
| Ordinary income | ¥186 million → ¥191 million（+2.6%） |
| Profit attributable to owners of the parent | ¥146 million → ¥150 million（+3.4%） |
| Net income per share | 16.05 yen and sen → 15.64 yen and sen（-2.6%） |
| Fiscal Period Covered | Fiscal year ending June 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 November 2025 |
| Previous-period results | Sales: ¥2,917 million; operating income: ¥196 million; ordinary income: ¥198 million; net income attributable to owners of the parent: ¥160 million; earnings per share: ¥17.64 |
| Reason for the revision | Acquisition and sales in INVASE's real estate transaction model have remained strong. In the Mogecheck business, efficient investment in advertising and promotional expenses progressed, while the INVASE business was temporarily affected in the third quarter by changes to banks' screening criteria. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The sales forecast was raised because acquisition and sales in INVASE's real estate transaction model have remained strong. On the profit side, efficient investment in advertising and promotional expenses progressed in the Mogecheck business, while the INVASE business was temporarily affected in the third quarter by changes to banks' screening criteria.